GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 8/25/2026 8:07:54 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Rev $26,955 -97.8% | Assets $9,176,362 | EPS -$0.10 | Export Earnings Model | |
| Vyome Holdings, Inc (HIND) | 8/12/2026 4:45:38 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $26,955 -97.8% | Assets $9,176,362 | EPS -$0.10 | |
| Vyome Holdings, Inc (HIND) | 5/29/2026 8:43:39 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $31,591 -97.2% | Assets $10,185,446 | EPS -$0.15 | Export Earnings Model | |
| Vyome Holdings, Inc (HIND) | 5/12/2026 4:11:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $31,591 -97.2% | Assets $10,185,446 | EPS -$0.15 | |
| Vyome Holdings, Inc (HIND) | 3/31/2026 6:15:15 AM | View | Proxy | SEC | Y 2025 | ||||||
| Vyome Holdings, Inc (HIND) | 3/26/2026 8:05:15 AM | View | Financials | Earnings | WIRE | Y 2025 | Rev $36,551 -98.0% | Assets $6,497,177 | EPS $5.14 | Export Earnings Model | |
| Vyome Holdings, Inc (HIND) | 3/18/2026 6:44:07 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $319,714 -96.0% | Assets $6,497,177 | EPS -$4.86 | |
| Vyome Holdings, Inc (HIND) | 11/19/2025 5:22:20 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $34,627 -98.5% | Assets $7,045,396 | EPS -$3.12 | Export Earnings Model | |
| Vyome Holdings, Inc (HIND) | 11/14/2025 5:02:27 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $34,627 -98.5% | Assets $7,045,396 | EPS -$3.12 | |
| Vyome Holdings, Inc (HIND) | 10/6/2025 6:16:53 AM | View | Proxy | SEC | Y 2024 | ||||||
| ReShape Lifesciences Inc. (HIND) | 8/14/2025 5:33:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,242,000 -36.8% | Assets $9,028,000 | EPS -$2.25 | |
| ReShape Lifesciences Inc. (HIND) | 5/21/2025 8:32:59 AM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $1,113,000 -42.7% | Assets $6,483,000 | EPS $18.98 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 5/20/2025 5:05:48 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,113,000 -42.7% | Assets $6,483,000 | EPS $18.98 | |
| ReShape Lifesciences Inc. (HIND) | 4/7/2025 4:06:46 PM | View | Financials | Earnings | WIRE | 1Q 2025 | Rev $1,113,000 -42.7% | Assets $6,483,000 | EPS $18.98 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 4/4/2025 4:21:59 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $8,006,000 -7.7% | Assets $4,793,000 | EPS -$345.27 | |
| ReShape Lifesciences Inc. (HIND) | 3/14/2025 4:36:38 PM | View | Proxy | SEC | Y 2024 | ||||||
| ReShape Lifesciences Inc. (HIND) | 11/14/2024 4:41:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,292,000 +6.4% | Assets $5,615,000 | EPS -$3.11 | |
| ReShape Lifesciences Inc. (HIND) | 11/14/2024 4:33:43 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,292,000 +6.4% | Assets $5,615,000 | EPS -$3.11 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 8/14/2024 4:45:59 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $1,965,000 -12.8% | Assets $6,393,000 | EPS -$3.67 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 8/14/2024 4:45:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,965,000 -12.8% | Assets $6,393,000 | EPS -$3.67 | |
| ReShape Lifesciences Inc. (HIND) | 5/20/2024 5:16:01 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $1,944,000 -15.0% | Assets $8,231,000 | EPS -$0.09 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 5/15/2024 5:08:56 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,944,000 -15.0% | Assets $8,231,000 | EPS -$0.09 | |
| ReShape Lifesciences Inc. (HIND) | 4/4/2024 11:14:04 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $1,982,000 -36.3% | Assets $10,663,000 | EPS -$2,563.92 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 4/1/2024 5:35:53 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $8,678,000 -22.8% | Assets $10,663,000 | EPS -$2,763.90 | |
| ReShape Lifesciences Inc. (HIND) | 1/24/2024 6:01:47 AM | View | Proxy | SEC | Y 2023 | ||||||
| ReShape Lifesciences Inc. (HIND) | 11/9/2023 6:17:51 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $2,155,000 -23.0% | Assets $7,827,000 | EPS -$59.36 | |
| ReShape Lifesciences Inc. (HIND) | 11/9/2023 6:01:42 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $2,155,000 -23.0% | Assets $7,827,000 | EPS -$59.36 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 8/7/2023 5:35:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $2,254,000 -22.1% | Assets $11,852,000 | EPS -$62.34 | |
| ReShape Lifesciences Inc. (HIND) | 8/7/2023 4:55:40 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $2,254,000 -22.1% | Assets $11,852,000 | EPS -$62.34 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 5/16/2023 6:02:28 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $2,287,000 -6.3% | Assets $16,352,000 | EPS -$1.56 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 5/15/2023 5:00:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $2,287,000 -6.3% | Assets $16,352,000 | EPS -$1.56 | |
| ReShape Lifesciences Inc. (HIND) | 4/25/2023 4:07:16 PM | View | Financials | Earnings | WIRE | Y 2022 | Rev $3,110,000 -1.0% | Assets $11,142,000 | EPS -$6,242.13 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 4/17/2023 5:09:50 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $11,240,000 -17.4% | Assets $11,142,000 | EPS -$6,315.92 | |
| ReShape Lifesciences Inc. (HIND) | 11/14/2022 5:35:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $2,798,000 -24.5% | Assets $26,485,000 | EPS -$27.01 | |
| ReShape Lifesciences Inc. (HIND) | 11/14/2022 4:55:47 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $2,798,000 -24.5% | Assets $26,485,000 | EPS -$27.01 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 11/10/2022 4:56:08 PM | View | Proxy | SEC | Y 2021 | ||||||
| ReShape Lifesciences Inc. (HIND) | 8/19/2022 5:29:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $2,892,000 -18.1% | Assets $40,357,000 | EPS -$24.45 | |
| ReShape Lifesciences Inc. (HIND) | 8/16/2022 6:06:46 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $2,892,000 -18.1% | Assets $40,357,000 | EPS -$24.45 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 5/23/2022 3:29:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $2,440,000 -24.2% | Assets $45,623,000 | EPS -$21.87 | |
| ReShape Lifesciences Inc. (HIND) | 5/23/2022 10:34:03 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $2,440,000 -24.2% | Assets $45,623,000 | EPS -$21.87 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 4/8/2022 5:29:06 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $13,600,000 +20.4% | Assets $52,531,000 | EPS -$288.97 | |
| ReShape Lifesciences Inc. (HIND) | 3/28/2022 5:32:22 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $3,142,000 -2.0% | Assets $52,531,000 | EPS -$138.66 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 3/22/2022 6:04:20 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| ReShape Lifesciences Inc. (HIND) | 3/17/2022 8:35:52 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| ReShape Lifesciences Inc. (HIND) | 11/12/2021 3:50:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $3,708,000 +2.9% | Assets $90,790,000 | EPS -$50.13 | |
| ReShape Lifesciences Inc. (HIND) | 11/12/2021 3:40:07 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $3,708,000 +2.9% | Assets $90,790,000 | EPS -$50.13 | Export Earnings Model | |
| ReShape Lifesciences Inc. (HIND) | 8/16/2021 11:42:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $3,529,000 +107.3% | Assets $120,013,000 | EPS -$42.70 | |
| ReShape Lifesciences Inc. (HIND) | 8/16/2021 11:20:35 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $3,529,000 +107.3% | Assets $120,013,000 | EPS -$42.70 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 5/12/2021 8:41:49 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $3,221,000 +312.9% | Assets $17,343,000 | EPS -$61.88 | |
| OBALON THERAPEUTICS INC (HIND) | 5/12/2021 8:31:09 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $3,221,000 +312.9% | Assets $17,343,000 | EPS -$61.88 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 3/12/2021 4:23:58 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $11,299,000 +244.4% | Assets $37,061,000 | EPS -$277.43 | |
| OBALON THERAPEUTICS INC (HIND) | 3/12/2021 4:11:31 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $3,207,000 +307.5% | Assets $37,061,000 | EPS -$274.07 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 11/6/2020 4:47:39 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $3,602,000 +981.7% | Assets $11,962,000 | EPS -$1.32 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 11/6/2020 4:44:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $3,602,000 +981.7% | Assets $11,962,000 | EPS -$1.32 | |
| OBALON THERAPEUTICS INC (HIND) | 8/10/2020 6:08:20 AM | View | Proxy | SEC | Y 2019 | ||||||
| OBALON THERAPEUTICS INC (HIND) | 7/30/2020 6:44:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $1,702,000 +340.9% | Assets $13,873,000 | EPS -$0.93 | |
| OBALON THERAPEUTICS INC (HIND) | 7/30/2020 6:42:51 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $1,702,000 +340.9% | Assets $13,873,000 | EPS -$0.93 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 6/19/2020 6:13:15 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $780,000 -56.1% | Assets $19,229,000 | EPS -$0.68 | |
| OBALON THERAPEUTICS INC (HIND) | 2/27/2020 9:09:13 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $3,281,000 -63.9% | Assets $20,393,000 | EPS -$5.03 | |
| OBALON THERAPEUTICS INC (HIND) | 2/27/2020 7:31:35 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $787,000 -61.3% | Assets $20,393,000 | EPS $0.04 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 11/8/2019 9:33:55 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $333,000 -88.9% | Assets $24,657,000 | EPS -$0.61 | |
| OBALON THERAPEUTICS INC (HIND) | 11/8/2019 9:01:45 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $333,000 -88.9% | Assets $24,657,000 | EPS -$0.61 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 7/24/2019 8:13:37 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $386,000 -85.9% | Assets $19,199,000 | EPS -$2.52 | |
| OBALON THERAPEUTICS INC (HIND) | 7/24/2019 7:48:44 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $386,000 -85.9% | Assets $19,199,000 | EPS -$2.52 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 6/13/2019 5:57:35 PM | View | Proxy | SEC | Y 2018 | ||||||
| OBALON THERAPEUTICS INC (HIND) | 5/10/2019 5:39:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $1,775,000 +31.9% | Assets $32,368,000 | EPS -$3.59 | |
| OBALON THERAPEUTICS INC (HIND) | 2/22/2019 9:14:23 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $9,101,000 -8.2% | Assets $30,386,000 | EPS -$19.64 | |
| OBALON THERAPEUTICS INC (HIND) | 2/22/2019 8:02:12 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $2,036,000 -44.9% | Assets $30,386,000 | EPS -$0.39 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 11/2/2018 8:35:59 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $2,987,000 +7.2% | Assets $36,879,000 | EPS -$3.47 | |
| OBALON THERAPEUTICS INC (HIND) | 11/2/2018 8:03:25 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $2,987,000 +7.2% | Assets $36,879,000 | EPS -$3.47 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 8/2/2018 8:44:37 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $2,732,000 +39.2% | Assets $32,471,000 | EPS -$0.57 | |
| OBALON THERAPEUTICS INC (HIND) | 8/2/2018 8:02:51 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $2,732,000 +39.2% | Assets $32,471,000 | EPS -$0.57 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 5/10/2018 4:55:05 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $1,346,000 -8.6% | Assets $40,507,000 | EPS -$0.71 | |
| OBALON THERAPEUTICS INC (HIND) | 5/10/2018 4:08:23 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $1,346,000 -8.6% | Assets $40,507,000 | EPS -$0.71 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 4/30/2018 4:12:10 PM | View | Proxy | SEC | Y 2017 | ||||||
| OBALON THERAPEUTICS INC (HIND) | 3/5/2018 4:39:52 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $9,914,000 +192.2% | Assets $53,101,000 | EPS -$2.08 | |
| OBALON THERAPEUTICS INC (HIND) | 3/5/2018 3:51:09 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $3,692,000 +378.2% | Assets $53,101,000 | EPS -$0.60 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 1/5/2018 9:00:46 AM | View | Financials | Earnings (Prelim) | SEC | Y 2017 | Export Earnings Model | ||||
| OBALON THERAPEUTICS INC (HIND) | 11/3/2017 9:11:49 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $2,787,000 +260.5% | Assets $59,078,000 | EPS -$0.55 | |
| OBALON THERAPEUTICS INC (HIND) | 11/3/2017 7:40:41 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $2,787,000 +260.5% | Assets $59,078,000 | EPS -$0.55 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 8/2/2017 9:09:51 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $1,963,000 +152.0% | Assets $64,978,000 | EPS -$0.46 | |
| OBALON THERAPEUTICS INC (HIND) | 8/2/2017 8:06:10 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $1,963,000 +152.0% | Assets $64,978,000 | EPS -$0.46 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 5/10/2017 9:03:11 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $1,472,000 +37.7% | Assets $70,590,000 | EPS -$0.47 | |
| OBALON THERAPEUTICS INC (HIND) | 5/10/2017 8:05:04 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $1,472,000 +37.7% | Assets $70,590,000 | EPS -$0.47 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 4/27/2017 8:30:57 AM | View | Proxy | SEC | Y 2016 | ||||||
| OBALON THERAPEUTICS INC (HIND) | 2/23/2017 8:58:49 AM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $3,393,000 -16.0% | Assets $78,778,000 | EPS -$4.85 | |
| OBALON THERAPEUTICS INC (HIND) | 2/23/2017 7:48:03 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $772,000 -21.5% | Assets $78,778,000 | EPS -$0.51 | Export Earnings Model | |
| OBALON THERAPEUTICS INC (HIND) | 11/10/2016 4:17:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $773,000 -29.3% | Assets $18,498,000 | EPS -$5.46 |